"To every thing there is a season, and a time to every purpose under heavenѧ" (Ecclesiastes 3:1). As recognized over the millennia in every culture, time and seasonal change impact life and are reflected in the physiology of living things. In physical chemistry, the second law of thermodynamics describes that in closed, isolated systems time is reflected by an increase in disorder (entropy) that disrupt the steadystate. However, living systems are not closed and respond to entropy by absorbing or chemically generating heat (energy) to achieve a dynamic equilibrium. In 1926, Walter Cannon introduced the term homeostasis as a fundamental principle of physiology. But in his concept of homeostasis, Cannon did not imply a static steady-state that ignores the disruptive influence of time. Indeed, Cannon recognized the importance of time variance in living systems and that relative stability across time is maintained only by physiological processes that achieve a dynamic equilibrium. In many respects, mitochondria are central to physiological homeostasis and must respond to time. The period of time over which dynamic equilibrium is achieved can vary from milliseconds to seconds to hours to days to months and years. In most cases, this is driven by environmental cues such as the daily light/dark cycle (diurnal and nocturnal rhythms) or seasonal changes in the length of each day. However, it can also be driven by internal perturbations of ionic gradients or the relentless changes of aging. Indeed, much of our research in physiology focuses on the impact of time-dependent variations and perturbations. The first review article in this issue of Physiology explores the fascinating role of melatonin in facilitating our homeostatic response of mitochondria to time and the daily and seasonal changes in the light/ dark cycle.
Melatonin is a ubiquitously acting molecule that was initially thought to be exclusively produced in the vertebrate pineal gland in a circadian manner, as dictated by the prevailing seasonal light/dark cycle. Thus the circadian melatonin rhythm provides organisms with time-of-day and time-of-year information, allowing species to change their physiology on a daily and seasonal basis. Research has revealed, however, that melatonin is far more than a timing agent. Melatonin is also a multipurpose antioxidant, an anti-cancer agent, and an anti-inflammatory molecule. Moreover, melatonin is not exclusively synthesized in the vertebrate pineal gland, as originally thought. Current evidence shows that melatonin exists and is synthesized in every subvertebrate animal species and in all plants, both of which lack a pineal gland. In fact, melatonin is believed to be produced in every cell of every organism that currently exists or has ever existed. Intracellularly, melatonin is synthesized in mitochondria and chloroplasts, one or both of which are present in every cell of every organism, with few exceptions. These intracellular sources of melatonin are used by the cells in which they are produced and mediate the local actions of melatonin. In their review (6), Reiter and colleagues discuss the means by which melatonin reduces mitochondrial irregularities resulting from excessive oxidative stress or as a consequence of the transformation of normal cells to a cancerous phenotype. At least in mammals, mitochondrial melatonin synthesis is presumably closely linked to glucose metabolism, since, in normal cells, glucose enters the cytosol where it is metabolized to pyruvate. Pyruvate subsequently enters the mitochondria, where it is converted to acetyl-CoA. In addition to enhancing the citric acid cycle and oxidative phosphorylation in the mitochondria, acetyl-CoA is also a necessary co-factor for the rate-limiting enzyme in melatonin synthesis. In the absence of acetyl-CoA, melatonin cannot be produced in mitochondria. This deficiency deprives cells of melatonin's antioxidant and anti-cancer actions, which contribute to diseases and aging. This area of research may lead to therapies for many mitochondrial-related diseases.
Aging has ever-present effects on our daily lives, including decreasing physical and mental capability, increased susceptibility to diseases, and ultimately death. In their review (3), Buffenstein et al. focus on the negligible aging phenotype of the naked mole-rat, a fascinating animal that exhibits excellent health often into its last years of life. They discuss the multiple prolonged pedomorphic traits observed in naked mole-rats and genetically engineered dwarf mice, both of which exhibit significantly extended health and lifespans, and remarkable resilience to stressors compared with similar-sized rodents. These negligible aging phenotypes are rarely observed in other mammals, making these animals a critical model for healthy human aging and longevity. Understanding the mechanisms underlying a single one of these pedomorphic traits, or a combination of multiple traits, has the potential to extend the health and life of any mammal, including humans. Many of the pedomorphic traits highlighted in this review are also observed humans, another species that is actually long-lived compared with other closely related primates. Those traits that are not shared with humans underscore potential avenues of research that could potentially give rise to novel therapeutic approaches that would lead to improved health and a reduction in age-associated diseases.
DNA sensing in cells is a critical aspect of the immune system. In a normal, healthy cell, DNA should be localized to the nucleus. However, when DNA is found in the cytosolic or endosomal compartments, it is a key indication that the cell is infected or has undergone damage and lost nuclear integrity. No matter what causes the mislocalization of DNA, the body needs to be able to sense this and respond appropriately to remove this cell and protect the host from the spread of infection or cellular damage. Without these DNA-sensing pathways, it would be more difficult to stop the spread of infection within the body. However, DNAsensing pathways can also become dys-regulated and cause overactivation of immune responses. This overactivation can contribute to autoimmune diseases and even cancer. In their review (2), Briard and colleagues discuss how cells sense DNA and regulate their responses to DNA mislocalization. DNA sensing is essential for ensuring appropriate immune responses to infections and damage while preventing overactivation and the inflammatory diseases that can result. Treatments that target the DNA sensing pathways could be used to improve the lives of patients living with inflammatory disease.
Adipose stem cells (ASCs) are an important source of stem cell therapy, since they can be easily obtained from adipose tissue in large quantities. Recent research has focused on the clinical application of ASCs for the treatment of a variety of diseases, such as Crohn's disease, multiple sclerosis, diabetes mellitus, heart diseases, and ischemia. In their review (1), Al-Ghadban and Bunnell discuss immunomodulatory effects of ASCs and mechanisms of action, including direct cell-cell communication with immune cells, ASCproduced soluble mediators, and exosomes. One of the most-applied techniques is the use of allogeneic ASC transplantations, especially for patients suffering from cancer. Administration of ASCs may also be used to repair damaged organs that result from injuries or chronic diseases. In both cases, ASCs enhance physiological function by supplying the body with fresh/new stem cells. These new stem cells once differentiated replace injured cells, decrease inflammatory cytokines, and restore the impaired organ. The same approach holds true for people suffering from age-related frailty, where injection of young ASCs through allogenic transplantation regenerates the patient's ability to adapt to their environment, thus lowering morbidities associated with aging. Overall, ASCs play a very important role in regenerative medicine. Continued research in this field holds great promise to improve the quality of life for patients.
Early human life begins at the onset of fertilization and ends with implantation of the embryo in the uterine wall. Approximately one-third of spontaneous conceptions end in loss within 22 weeks of gestation, and even with assisted reproductive technology interventions, the rate of live births per cycle of intervention is 31% for women under 35, decreasing to 8% for women after the age of 40. The underlying cause for this high rate of failure is likely related to early stages of embryo transport and implantation. In their review (4), Elad and colleagues discuss the molecular and biomechanical mechanisms relevant to the period of early human life in the female reproductive tract. The difficulty of performing in vivo studies in humans, together with the fact that animal studies are not always applicable to humans, are barriers to further understanding the mechanisms that underlie reproductive failure. Tissue engineering of in vitro biological models that mimic the anatomical architecture and physiological performance of the real in vivo organs offers an opportunity to increase the number of successful pregnancies while avoiding accessibility and ethical limitations.
Female breasts are specialized exocrine glands located on the anterior chest between the sternum and midaxillary line, and overlying the superficial muscles of the anterior-lateral chest wall. Although approximately half the world's population develop breasts, the scientific literature documenting breast structure and motion is limited. In their review (5), McGhee and Steele discuss the structure and motion of the female breast, and how this affects mechanical loading of the upper torso. The authors identify current gaps in our knowledge in this field that may guide future research related to breast biomechanics. A better understanding of breast biomechanics can have numerous applications, including surgical reconstruction following breast cancer surgery, modeling the breast to aid in diagnosing and treating breast pathologies, or simply designing effective bras that will comfortably support a woman's breasts so she can enjoy the numerous health benefits associated with an active lifestyle. Ⅲ
No conflicts of interest, financial or otherwise, are declared by the author.
